144 related articles for article (PubMed ID: 30321495)
1. Beyond contraception and hormone replacement therapy: Advancing Nestorone to a neuroprotective drug in the clinic.
Tuazon JP; Sitruk-Ware R; Borlongan CV
Brain Res; 2019 Feb; 1704():161-163. PubMed ID: 30321495
[TBL] [Abstract][Full Text] [Related]
2. Reprint of: Beyond contraception and hormone replacement therapy: Advancing Nestorone to a neuroprotective drug in the clinic.
Tuazon JP; Sitruk-Ware R; Borlongan CV
Brain Res; 2019 Sep; 1719():285-287. PubMed ID: 31213288
[TBL] [Abstract][Full Text] [Related]
3. Contraceptive drug, Nestorone, enhances stem cell-mediated remodeling of the stroke brain by dampening inflammation and rescuing mitochondria.
Lee JY; Castelli V; Kumar N; Sitruk-Ware R; Borlongan CV
Free Radic Biol Med; 2022 Apr; 183():138-145. PubMed ID: 35341914
[TBL] [Abstract][Full Text] [Related]
4. Nestorone (segesterone acetate) effects on neuroregeneration.
Sitruk-Ware R; Sussman H; Brinton R; Schumacher M; Singer P; Kumar N; De Nicola AF; El-Etr M; Guennoun R; V Borlongan C
Front Neuroendocrinol; 2024 Apr; 73():101136. PubMed ID: 38670433
[TBL] [Abstract][Full Text] [Related]
5. Nestorone exerts long-term neuroprotective effects against transient focal cerebral ischemia in adult male rats.
Tanaka M; Ogaeri T; Samsonov M; Sokabe M
Brain Res; 2019 Sep; 1719():288-296. PubMed ID: 30244019
[TBL] [Abstract][Full Text] [Related]
6. Sex differences in the cerebroprotection by Nestorone intranasal delivery following stroke in mice.
Fréchou M; Zhu X; Kumar N; Sitruk-Ware R; Schumacher M; Mattern C; Guennoun R
Neuropharmacology; 2021 Oct; 198():108760. PubMed ID: 34437904
[TBL] [Abstract][Full Text] [Related]
7. Nestorone: clinical applications for contraception and HRT.
Sitruk-Ware R; Small M; Kumar N; Tsong YY; Sundaram K; Jackanicz T
Steroids; 2003 Nov; 68(10-13):907-13. PubMed ID: 14667982
[TBL] [Abstract][Full Text] [Related]
8. Progress in progestin-based therapies for neurological disorders.
Sitruk-Ware R; Bonsack B; Brinton R; Schumacher M; Kumar N; Lee JY; Castelli V; Corey S; Coats A; Sadanandan N; Gonzales-Portillo B; Heyck M; Shear A; Blaise C; Zhang H; Sheyner M; García-Sánchez J; Navarro L; El-Etr M; De Nicola AF; Borlongan CV
Neurosci Biobehav Rev; 2021 Mar; 122():38-65. PubMed ID: 33359391
[TBL] [Abstract][Full Text] [Related]
9. Nestorone: a progestin with a unique pharmacological profile.
Kumar N; Koide SS; Tsong Y; Sundaram K
Steroids; 2000; 65(10-11):629-36. PubMed ID: 11108869
[TBL] [Abstract][Full Text] [Related]
10. Progesterone receptors: a key for neuroprotection in experimental stroke.
Liu A; Margaill I; Zhang S; Labombarda F; Coqueran B; Delespierre B; Liere P; Marchand-Leroux C; O'Malley BW; Lydon JP; De Nicola AF; Sitruk-Ware R; Mattern C; Plotkine M; Schumacher M; Guennoun R
Endocrinology; 2012 Aug; 153(8):3747-57. PubMed ID: 22635678
[TBL] [Abstract][Full Text] [Related]
11. Progesterone and related progestins: potential new health benefits.
Sitruk-Ware R; El-Etr M
Climacteric; 2013 Aug; 16 Suppl 1():69-78. PubMed ID: 23647429
[TBL] [Abstract][Full Text] [Related]
12. The progesterone receptor agonist Nestorone holds back proinflammatory mediators and neuropathology in the wobbler mouse model of motoneuron degeneration.
Meyer M; Gonzalez Deniselle MC; Garay L; Sitruk-Ware R; Guennoun R; Schumacher M; De Nicola AF
Neuroscience; 2015 Nov; 308():51-63. PubMed ID: 26349009
[TBL] [Abstract][Full Text] [Related]
13. Subdermal contraceptive implants.
Peralta O; Diaz S; Croxatto H
J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):223-6. PubMed ID: 7626459
[TBL] [Abstract][Full Text] [Related]
14. Nestorone® as a Novel Progestin for Nonoral Contraception: Structure-Activity Relationships and Brain Metabolism Studies.
Kumar N; Fagart J; Liere P; Mitchell SJ; Knibb AR; Petit-Topin I; Rame M; El-Etr M; Schumacher M; Lambert JJ; Rafestin-Oblin ME; Sitruk-Ware R
Endocrinology; 2017 Jan; 158(1):170-182. PubMed ID: 27824503
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of the selective progesterone receptor agonist Nestorone for chronic experimental autoimmune encephalomyelitis.
Garay L; Gonzalez Deniselle MC; Sitruk-Ware R; Guennoun R; Schumacher M; De Nicola AF
J Neuroimmunol; 2014 Nov; 276(1-2):89-97. PubMed ID: 25200475
[TBL] [Abstract][Full Text] [Related]
16. Developing drug strategies for the neuroprotective treatment of acute ischemic stroke.
Tuttolomondo A; Pecoraro R; Arnao V; Maugeri R; Iacopino DG; Pinto A
Expert Rev Neurother; 2015; 15(11):1271-84. PubMed ID: 26469760
[TBL] [Abstract][Full Text] [Related]
17. Neurosteroids and Ischemic Stroke: Progesterone a Promising Agent in Reducing the Brain Injury in Ischemic Stroke.
Andrabi SS; Parvez S; Tabassum H
J Environ Pathol Toxicol Oncol; 2017; 36(3):191-205. PubMed ID: 29283333
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effect of epidermal growth factor plus growth hormone-releasing peptide-6 resembles hypothermia in experimental stroke.
Subirós N; Pérez-Saad H; Aldana L; Gibson CL; Borgnakke WS; Garcia-Del-Barco D
Neurol Res; 2016 Nov; 38(11):950-958. PubMed ID: 27665924
[TBL] [Abstract][Full Text] [Related]
19. Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions.
Gladstone DJ; Black SE; Hakim AM;
Stroke; 2002 Aug; 33(8):2123-36. PubMed ID: 12154275
[TBL] [Abstract][Full Text] [Related]
20. Synergetic neuroprotection of normobaric oxygenation and ethanol in ischemic stroke through improved oxidative mechanism.
Geng X; Fu P; Ji X; Peng C; Fredrickson V; Sy C; Meng R; Ling F; Du H; Tan X; Hüttemann M; Guthikonda M; Ding Y
Stroke; 2013 May; 44(5):1418-25. PubMed ID: 23512978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]